Topics
Glioblastoma | Treatment | Pharmacotherapy | Antidepressant drugs
Home > Publications > Topics > Glioblastoma > Treatment > Pharmacotherapy > Antidepressant drugs
Kast RE, Marques Vieira B, Barros da Silva E Jr.
A
New Adjuvant Treatment for Glioblastoma Using Aprepitant,
Vortioxetine, Roflumilast and Olanzapine: The AVRO Regimen.
Int
J Mol Sci. 2025 Jun 26;26(13):6158. doi:
10.3390/ijms26136158. PMID:
40649933. Review. ˍ
Sun Y, Hamo M, Atchley T, Markert JM, Nabors B, Estevez-Ordonez D.
Survival Outcomes Associated with
Antidepressant Use in Glioblastoma: A Cohort Study.
Res
Sq [Preprint]. 2025 Aug 19:rs.3.rs-7339610. doi:
10.21203/rs.3.rs-7339610/v1. PMID:
40894022. Observational study. ˍ
J
Neurooncol. 2025 Oct 27;176(1):47. doi:
10.1007/s11060-025-05288-3. PMID:
41144062. Observational study. ˍ